Tacrolimus Treatment for Refractory PRCA

Clinical trial NCT03540472 · UNKNOWN

Trial details

NCT number: NCT03540472
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Pure Red Cell Aplasia

Start date: 2018-06-10
Primary completion: 2018-12-10
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.